Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34767461

Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2022 Mar 20
First author
Myers RM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2022 Mar 20;40(9):921-923. doi: 10.1200/JCO.21.02465.
    note
    Source null
    related pmid
    34767437
    relationship
    Comment in

Authors and identifiers

  1. name
    Myers RM
    type
    Author
  2. name
    Taraseviciute A
    type
    Author
  3. name
    Steinberg SM
    type
    Author
  4. name
    Lamble AJ
    type
    Author
  5. name
    Sheppard J
    type
    Author
  6. name
    Yates B
    type
    Author
  7. name
    Kovach AE
    type
    Author
  8. name
    Wood B
    type
    Author
  9. name
    Borowitz MJ
    type
    Author
  10. name
    Stetler-Stevenson M
    type
    Author
  11. name
    Yuan CM
    type
    Author
  12. name
    Pillai V
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Myers RM
    type
    Author
  2. name
    Taraseviciute A
    type
    Author
  3. name
    Steinberg SM
    type
    Author
  4. name
    Lamble AJ
    type
    Author
  5. name
    Sheppard J
    type
    Author
  6. name
    Yates B
    type
    Author
  7. name
    Kovach AE
    type
    Author
  8. name
    Wood B
    type
    Author
  9. name
    Borowitz MJ
    type
    Author
  10. name
    Stetler-Stevenson M
    type
    Author
  11. name
    Yuan CM
    type
    Author
  12. name
    Pillai V
    type
    Author
bibliography ids
  1. nci-bib-dc8565697558ecdc44841e46
book metadata
content sha256
56519eb4f6a353cb46d13dd549fd9997e12a1139b60afbbfb75bed17c7605e89
document type
citation
dois
  1. 10.1200/JCO.21.01405
electronic publication date
display
2021 Nov 12
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34767461
immutable id
pubmed:34767461@56519eb4f6a353cb46d13dd549fd9997e12a1139b60afbbfb75bed17c7605e89
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
9
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
932-944
volume
40
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2022 Mar 20;40(9):921-923. doi: 10.1200/JCO.21.02465.
    note
    Source null
    related pmid
    34767437
    relationship
    Comment in
outcomes validated
false
pmid
34767461
provenance
batch id
3f4d1914d2afe41e9e70
provider
NCBI PubMed ESummary
record sha256
0a05564bc4ec7674c63a1b8c25e805436a59f7afd3bcda59134c566ba7ce6aeb
response sha256
0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
retrieved at
2026-09-09T23:48:06.522634+00:00
publication date
display
2022 Mar 20
precision
day
year
2022
publication types
  1. Journal Article
  2. Multicenter Study
  3. Research Support, N.I.H., Intramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34767461/
title
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL.

Preserved source evidence · Not medical advice